Principal Investigator:
Rafal Goraczniak
Award Amount:
$189,496.00
DESCRIPTION (provided by applicant): The goal of Phase I of this SBIR application is to establish the feasibility of using a newly invented gene silencing technology called U1 Adaptors that uses Adaptor oligonucleotides to silence the human BCL2 gene, a ke
y player in tumor progression. The long…
More